Potential regulatory mechanisms of lncRNA in diabetes and its complications

被引：62

作者：

Feng, Shui-Dong ^{[1
]}

Yang, Ji-Hua ^{[2
]}

Yao, Chao Hua ^{[3
]}

Yang, Si-Si ^{[2
]}

Zhu, Ze-Mei ^{[2
]}

Wu, Di ^{[2
]}

Ling, Hong-Yan ^{[2
]}

Zhang, Liang ^{[3
]}

机构：

[1] Univ South China, Sch Publ Hlth, Dept Social Med & Hlth Serv Management, Hengyang, Peoples R China

[2] Univ South China, Sch Med, Dept Physiol, Hengyang, Peoples R China

[3] Palmer Ctr Chiropract Res, Lab Cell & Mol Biol, Port Orange, FL 32129 USA

来源：

BIOCHEMISTRY AND CELL BIOLOGY | 2017年 / 95卷 / 03期

关键词：

lncRNA; diabetes; diabetic complications; LONG NONCODING RNA; GROWTH-FACTOR-BETA; STAGE RENAL-DISEASE; INSULIN-SECRETION; PANCREATIC-ISLETS; DOWN-REGULATION; CELL FUNCTION; GLUCOSE; GENE; EXPRESSION;

D O I：

10.1139/bcb-2016-0110

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Long non-coding RNAs ( lncRNAs) are transcripts longer than 200 nucleotides without protein-coding potential. Although these molecules were initially considered as "junk products" of transcription without biological relevance, recent advances in research have shown that lncRNA plays an important role, not only in cellular processes such as proliferation, differentiation, and metabolism, but also in the pathological processes of cancers, diabetes, and neurodegenerative diseases. In this review, we focus on the potential regulatory roles of lncRNA in diabetes and the complications associated with diabetes.

引用

页码：361 / 367

页数：7

共 50 条

[31] Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
Ramasamy, Ravichandran
Yan, Shi Fang
Schmidt, Ann Marie
YEAR IN DIABETES AND OBESITY, 2011, 1243 : 88 - 102
[32] Photobiomodulation for diabetes and its complications: a review of general presentation, mechanisms and efficacy
Wang, Keyan
Zhao, Hongwei
Zhao, Xiaoqing
Zhang, Xiaoyu
Zhang, Wei
Cheng, Yan
Ge, Jingyan
ANNALS OF MEDICINE, 2024, 56 (01)
[33] The potential of esculin as a therapeutic modality in diabetes mellitus and its complications
Naseem, Nida
Ahmad, Md. Fahim
Imam, Nazia
Ahsan, Haseeb
Siddiqui, Waseem A.
HUMAN NUTRITION & METABOLISM, 2023, 33
[34] Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers
Hu, Qiuhui
Tai, Sheng
Wang, Jicai
PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (05) : 843 - 848
[35] Oncogenic roles of lncRNA BLACAT1 and its related mechanisms in human cancers
Han, Wei
Yu, Fan
Guan, Wei
BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
[36] Recent Advances of LncRNA H19 in Diabetes LncRNA H19 in Diabetes
Bi, Ye
Wang, Yao
Sun, Xianglan
HORMONE AND METABOLIC RESEARCH, 2022, 54 (04) : 212 - 219
[37] Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications
Lu, Xiaolin
Tan, Qihong
Ma, Jianyong
Zhang, Jing
Yu, Peng
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
[38] The Therapeutic Potential and Role of miRNA, lncRNA, and circRNA in Osteoarthritis
Wu, Yuangang
Lu, Xiaoxi
Shen, Bin
Zeng, Yi
CURRENT GENE THERAPY, 2019, 19 (04) : 255 - 263
[39] Understanding the lncRNA/miRNA-NFκB regulatory network in diabetes mellitus: From function to clinical translation
Hoorzad, Parisa
Mousavinasab, Fatemehsadat
Tofigh, Pouya
Kalahroud, Elham Mazaheri
Aghaei-Zarch, Seyed Mohsen
Salehi, Ali
Fattahi, Mehdi
Le, Binh Nguyen
DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 202
[40] Sulfonyl Group-Containing Compounds in the Design of Potential Drugs for the Treatment of Diabetes and Its Complications
Chen, X.
Hussain, S.
Parveen, S.
Zhang, S.
Yang, Y.
Zhu, C.
CURRENT MEDICINAL CHEMISTRY, 2012, 19 (21) : 3578 - 3604

← 1 2 3 4 5 →